Skip to main content
Fig. 7 | Human Genomics

Fig. 7

From: Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer

Fig. 7

Nomogram and its predictive performance. a Nomogram predicting 3-, 5-, and 8-year biochemical recurrence-free survival (BCRFS) for patients diagnosed with prostate cancer (PCa). The performance of the nomogram is evaluated through receiver operating characteristic (ROC) curves in The Cancer Genome Atlas Prostate Adenocarcinoma (TCGA-PRAD) training set (b), the testing set (c), and the complete set (d)

Back to article page